Fundamental Data for ACL

Alcon, Inc. develops, manufactures and markets ophthalmic pharmaceuticals, ophthalmic surgical equipment and devices, contact lens care products and other consumer eye care products that treat diseases and conditions of the eye. With the exception of eye-glasses and contact lenses, they operate in all areas of ophthalmology.

# Employees: 12700

Address: B??sch 69 P.O. Box 62,H??nenberg,,SWE

Phone: 800-400-8599

Fax:

Website: www.alconinc.com

Email: investor.relations@alconlabs.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Jacqualyn A. Fouse (Sr. V.P.; Fin.; C.F.O.)

Andr?? G. Bens Dr. (Sr. V.P.; Global Manufacturing & Tech. Support)

Gerald D. Cagle Dr. (Sr. V.P.; Res. & Develop.)

Cary R. Rayment (Sr. V.P.,)

Dividend

Ex-Dividend Date: 1/1/1990

Annual Dividend: $3.64

Current Dividend Yield: $2.51

Dividend Paid (3 months): $0.00

Indicated Dividend: $0.55

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/10/2010

Mean EPS (Next Qtr): $1.50

Mean EPS (Year): $6.70

Mean Estimate(Long Term): $12.75

P/E Ratio(Based on EPS estimate): 21.680

Number of Estimates: 13

Shares Performance

Period	ACL	Compare to S&P
YTD	62.87 %	34.79 %
4 Weeks	-0.93 %	-2.00 %
12 Weeks	12.44 %	6.01 %

Shares Information

Analyst Coverage: Y

Avg Volume: 599509

Shares Outstanding: 298M

Market Cap: $43.40B

52 Week High: $147.63

52 Week Low: $67.98

P/E Ratio: 21.980

PEG Ratio: 1.700

Split: On 1/1/1990 ACL split by factor of 0.100

Earnings Performance

EPS Growth in Last Quarter: -11.86 %

EPS Growth in Last Year: 33.59 %

Sales Growth in Last Quarter: -3.76 %

Sales Growth in Last Quarter: 5.86 %

Financials

Qtr Book Value: $8.04

Cash Flow/Share: $21.71

Change in Payout Ratio: 0.190

Price/Sales: 6.910